Clearance Summary
ACS:180 AND ADVIA CENTAUR B-TYPE NATRIURETIC PEPTIDE (BNP) ASSAYS received FDA 510(k) clearance under submission number K040425, sponsored by Bayer Healthcare, LLC. The device was reviewed via the Traditional premarket notification pathway and assigned to the Clinical Chemistry review panel. The statutory decision date of record is 2004-06-14.
- Submission: K040425
- Applicant / Sponsor: Bayer Healthcare, LLC
- Clearance pathway: Traditional
- Review panel: Clinical Chemistry
- Device class: Class II
- Regulation citation: 21 CFR 862.1117
- Decision date: 2004-06-14
Classification & Regulation
This clearance is catalogued under FDA product code NBC and 21 CFR 862.1117, within the Clinical Chemistry review panel as a Class II device.